These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 893417)

  • 21. The Hageman factor dependent pathways of coagulation, fibrinolysis, and kinin-generation.
    Kaplan AP; Meier HL; Mandle R
    Semin Thromb Hemost; 1976 Jul; 3(1):1-26. PubMed ID: 139682
    [No Abstract]   [Full Text] [Related]  

  • 22. Surface activation of blood coagulation, fibrinolysis and kinin formation.
    Heimark RL; Kurachi K; Fujikawa K; Davie EW
    Nature; 1980 Jul; 286(5772):456-60. PubMed ID: 6447254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nomenclature of factor XI and the contact system.
    Schmaier AH; Emsley J; Feener EP; Gailani D; Govers-Riemslag JWP; Kaplan AP; Maas C; Morrissey JH; Renné T; Sidelmann JJ; Meijers JCM
    J Thromb Haemost; 2019 Dec; 17(12):2216-2219. PubMed ID: 31410964
    [No Abstract]   [Full Text] [Related]  

  • 24. [Biochemical mechanism of blood coagulation (author's transl)].
    Maki M
    Rinsho Byori; 1981 Jan; 29(1):1-10. PubMed ID: 7289094
    [No Abstract]   [Full Text] [Related]  

  • 25. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.
    Griffin JH; Cochrane CG
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2554-8. PubMed ID: 1066663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of activation of bovine factor XI by factor XII and factor XIIa.
    Kurachi K; Fujikawa K; Davie EW
    Biochemistry; 1980 Apr; 19(7):1330-8. PubMed ID: 6155942
    [No Abstract]   [Full Text] [Related]  

  • 27. Circulating anticoagulant against factors XI and XII together with massive spontaneous platelet aggregation.
    Cronberg S; Nilsson IM
    Scand J Haematol; 1973; 10(4):309-14. PubMed ID: 4587560
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prothrombin activation mechanism].
    Sakuragawa N
    Nihon Rinsho; 1974 May; 32(5):901-9. PubMed ID: 4603779
    [No Abstract]   [Full Text] [Related]  

  • 29. Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation.
    Maas C; Govers-Riemslag JW; Bouma B; Schiks B; Hazenberg BP; Lokhorst HM; Hammarström P; ten Cate H; de Groot PG; Bouma BN; Gebbink MF
    J Clin Invest; 2008 Sep; 118(9):3208-18. PubMed ID: 18725990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification and characterization of platelet factor XI.
    Schiffman S; Yeh CH
    Thromb Res; 1990 Oct; 60(1):87-97. PubMed ID: 2278039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Protein and gene structures of the contact factors and their abnormalities].
    Fujikawa K; Asakai R
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):976-83. PubMed ID: 3270916
    [No Abstract]   [Full Text] [Related]  

  • 32. The importance of surfaces in contact phase reactions.
    Vroman L
    Semin Thromb Hemost; 1987 Jan; 13(1):79-85. PubMed ID: 3551077
    [No Abstract]   [Full Text] [Related]  

  • 33. Preparation, characterization, and activation of a highly purified factor XI: evidence that a hitherto unrecognized plasma activity participates in the interaction of factors XI and XII.
    Schiffman S; Lee P
    Br J Haematol; 1974 May; 27(1):101-14. PubMed ID: 4137120
    [No Abstract]   [Full Text] [Related]  

  • 34. Factor XI and factor XII as targets for new anticoagulants.
    Weitz JI
    Thromb Res; 2016 May; 141 Suppl 2():S40-5. PubMed ID: 27207423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The possible role of platelets in bypassing the contact phase of blood coagulation.
    Walsh PN; Tuszynski GP; Greengard JS; Griffin JH
    Haematologia (Budap); 1984; 17(2):169-78. PubMed ID: 6534825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contact phase of blood coagulation in diabetes mellitus.
    Patrassi GM; Vettor R; Padovan D; Girolami A
    Eur J Clin Invest; 1982 Aug; 12(4):307-11. PubMed ID: 6814921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgE-induced blood coagulation alterations in the rabbit: consumption of coagulation factors XII, XI, and IX in vivo.
    Pinckard RN; Tanigawa C; Halonen M
    J Immunol; 1975 Aug; 115(2):525-32. PubMed ID: 50367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New targets for atherothrombosis.
    Mackman N
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1607-8. PubMed ID: 25031326
    [No Abstract]   [Full Text] [Related]  

  • 39. Theory of blood coagulation in disseminated intravascular coagulation (D. I. C.).
    Murano G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 97(1):5-19. PubMed ID: 4114585
    [No Abstract]   [Full Text] [Related]  

  • 40. Recent advances in the understanding of contact activation reactions.
    Griffin JH; Cochrane CG
    Semin Thromb Hemost; 1979; 5(4):254-73. PubMed ID: 386517
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.